Aflibercept for ROP Shows Sustained Efficacy at Age 3 ...Middle East

Medscape - News
Myopia was less common and less severe in patients who received aflibercept than in patients who received laser photocoagulation, a study shows. Medscape Medical News

Hence then, the article about aflibercept for rop shows sustained efficacy at age 3 was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aflibercept for ROP Shows Sustained Efficacy at Age 3 )

Apple Storegoogle play

Last updated :

Also on site :